{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T09:08:55Z","timestamp":1785402535409,"version":"3.56.0"},"reference-count":65,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Primary biliary cholangitis (PBC) is a chronic autoimmune cholestatic liver disease primarily affecting the intrahepatic small bile ducts. Although PBC is mainly a hepatobiliary disease, renal abnormalities have been reported in a subset of patients and should be regarded as uncommon but clinically relevant extrahepatic manifestations. Reported glomerular lesions in patients with PBC include membranous nephropathy, immunoglobulin A nephropathy, crescentic glomerulonephritis, and minimal change disease, although most evidence is derived from case reports and small series. Tubulointerstitial involvement has also been described, most commonly as distal renal tubular acidosis in reported cases and less commonly as Fanconi syndrome; these conditions may reflect immune-mediated tubular dysfunction in selected patients. In addition, metabolic disturbances secondary to cholestasis and tubular injury may increase the risk of nephrolithiasis and nephrocalcinosis, whereas advanced cirrhosis can precipitate hepatorenal syndrome. Limited reports further suggest that cholestatic nephropathy and drug-related nephrotoxicity may contribute to renal impairment in selected patients. From a mechanistic perspective, immune complex deposition, T-cell\u2013mediated inflammation, mitochondrial dysfunction, cholestatic\/metabolic disturbances, and gut microbiota dysbiosis have been proposed as potential contributors, but direct causal evidence remains limited. Given the heterogeneity and potential clinical significance of renal manifestations in PBC, early detection, thorough nephrological assessment, and individualized therapeutic strategies are essential.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1845113","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T08:02:12Z","timestamp":1785398532000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Liver\u2013kidney crosstalk in primary biliary cholangitis: insights into the mechanisms of renal involvement"],"prefix":"10.3389","volume":"17","author":[{"given":"Zhaoyang","family":"Fan","sequence":"first","affiliation":[{"name":"Department of Nephrology, Affiliated Hospital of Shandong Second Medical University, School of Clinical Medicine, Shandong Second Medical University","place":["Weifang, China"]},{"name":"Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siqi","family":"Jia","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Fan","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangling","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Affiliated Hospital of Shandong Second Medical University, School of Clinical Medicine, Shandong Second Medical University","place":["Weifang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(20)31607-x","article-title":"Primary biliary cholangitis","volume":"396","author":"Lleo","year":"2020","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31776","article-title":"Male sex is associated with higher rates of liver-related mortality in primary biliary cholangitis and cirrhosis","volume":"74","author":"John","year":"2021","journal-title":"Hepatology"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32405","article-title":"Mechanisms and molecules: What are the treatment targets for primary biliary cholangitis","volume":"76","author":"Mayo","year":"2022","journal-title":"Hepatology"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2025.03.025","article-title":"Global epidemiology of primary biliary cholangitis: An updated systematic review and meta-analysis","volume":"24","author":"Tan","year":"2026","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29675","article-title":"Using the Icelandic genealogical database to define the familial risk of primary biliary cholangitis","volume":"68","author":"\u00d6rnolfsson","year":"2018","journal-title":"Hepatology"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20907","article-title":"Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients","volume":"42","author":"Gershwin","year":"2005","journal-title":"Hepatology"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.04.035","article-title":"Cholestatic pruritus: Emerging mechanisms and therapeutics","volume":"81","author":"Patel","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s00535-021-01839-3","article-title":"Distinct prognostic value of different portal hypertension-associated features in patients with primary biliary cholangitis","volume":"57","author":"Burghart","year":"2022","journal-title":"J Gastroenterol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1080\/00365520802400883","article-title":"Pulmonary hypertension in primary biliary cirrhosis: a prospective study in 178 patients","volume":"44","author":"Shen","year":"2009","journal-title":"Scand J Gastroenterol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1097\/mcg.0b013e31818aa11e","article-title":"Primary biliary cirrhosis complicated with interstitial lung disease: a prospective study in 178 patients","volume":"43","author":"Shen","year":"2009","journal-title":"J Clin Gastroenterol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1159\/000229189","article-title":"Primary biliary cirrhosis-related autoimmune hemolytic anemia: Three case reports and review of the literature","volume":"3","author":"Tian","year":"2009","journal-title":"Case Rep Gastroenterol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.aohep.2022.100746","article-title":"Prevalence and impact of Sj\u00f6gren's syndrome in primary biliary cholangitis: a systematic review and meta-analysis","volume":"27","author":"Deng","year":"2022","journal-title":"Ann Hepatol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-026-02442-0","article-title":"Prevalence and incidence of chronic kidney disease in patients with primary biliary cholangitis","author":"Sousa","year":"2026","journal-title":"J Gastroenterol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-022-00816-y","article-title":"Glomerulonephritis: immunopathogenesis and immunotherapy","volume":"23","author":"Anders","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-025-01131-y","article-title":"Kidney immunology from pathophysiology to clinical translation","volume":"25","author":"Kurts","year":"2025","journal-title":"Nat Rev Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-019-0141-9","article-title":"Lupus nephritis","volume":"6","author":"Anders","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"B17","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41572-020-0204-y","article-title":"ANCA-associated vasculitis","volume":"6","author":"Kitching","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-024-06994-5","article-title":"Glomerulonephritis in primary biliary cholangitis in China: an important complication","volume":"43","author":"Bian","year":"2024","journal-title":"Clin Rheumatol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000042770","article-title":"A case of membranous nephropathy complicated by autoimmune hepatitis and primary biliary cholangitis","volume":"104","author":"Lei","year":"2025","journal-title":"Med (Baltimore)"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.50.4020","article-title":"A case of membranous nephropathy with primary biliary cirrhosis and cyclosporine-induced remission","volume":"50","author":"Sakamaki","year":"2011","journal-title":"Intern Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"36","DOI":"10.5414\/cn110363","article-title":"Membranous nephropathy and primary biliary cholangitis: A case report and review of the literature","volume":"96","author":"Zimmermann","year":"2021","journal-title":"Clin Nephrol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s12328-012-0321-6","article-title":"Membranous nephropathy associated with primary biliary cirrhosis and acute meningitis","volume":"5","author":"Sato","year":"2012","journal-title":"Clin J Gastroenterol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.5414\/cn110892","article-title":"Coexistence of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome and membranous nephropathy: A case report","volume":"99","author":"Hong","year":"2023","journal-title":"Clin Nephrol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000001243","article-title":"Membranous nephropathy associated with immunological disorder-related liver disease: A retrospective study of 10 cases","volume":"94","author":"Dauvergne","year":"2015","journal-title":"Med (Baltimore)"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-025-00980-z","article-title":"Antigens in membranous nephropathy: discovery and clinical implications","volume":"21","author":"Sethi","year":"2025","journal-title":"Nat Rev Nephrol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/nejmoa0810457","article-title":"M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy","volume":"361","author":"Beck","year":"2009","journal-title":"N Engl J Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1146\/annurev-med-050522-034537","article-title":"Novel antigens and clinical updates in membranous nephropathy","volume":"75","author":"Avasare","year":"2024","journal-title":"Annu Rev Med"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2020.09.016","article-title":"Neural cell adhesion molecule 1 is a novel autoantigen in membranous lupus nephritis","volume":"100","author":"Caza","year":"2021","journal-title":"Kidney Int"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2018080852","article-title":"Exostosin 1\/Exostosin 2-associated membranous nephropathy","volume":"30","author":"Sethi","year":"2019","journal-title":"J Am Soc Nephrol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.608741","article-title":"Membranous nephropathy with monoclonal IgM lambda deposits in a patient with IgM monoclonal gammopathy: A case report","volume":"8","author":"Hirose","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-021-00768-y","article-title":"Clinical characteristics and outcomes of idiopathic membranous nephropathy with glomerular IgM deposits","volume":"22","author":"Xu","year":"2022","journal-title":"Clin Exp Med"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1055\/s-2004-835278","article-title":"Autoimmune cholangitis with vasculitic ulcers, rheumatoid arthritis and IgA glomerulonephritis","volume":"129","author":"Schedel","year":"2004","journal-title":"Dtsch Med Wochenschr"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.5217-24","article-title":"Latent tubulointerstitial nephritis with IgM-positive plasma cells uncovered in a case of IgA nephropathy and primary biliary cholangitis: Clinical and histological insights","volume":"64","author":"Saiki","year":"2025","journal-title":"Intern Med"},{"key":"B34","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41572-023-00476-9","article-title":"IgA nephropathy","volume":"9","author":"Stamellou","year":"2023","journal-title":"Nat Rev Dis Primers"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1056\/nejmra1206793","article-title":"IgA nephropathy","volume":"368","author":"Wyatt","year":"2013","journal-title":"N Engl J Med"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfaf144","article-title":"What do clinical trials teach us about the pathophysiology of human IgA nephropathy","author":"Konda","year":"2025","journal-title":"Nephrol Dial Transplant"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2016-313332","article-title":"Gut microbial profile is altered in primary biliary cholangitis and partially restored after UDCA therapy","volume":"67","author":"Tang","year":"2018","journal-title":"Gut"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.7150\/thno.49778","article-title":"Perspectives on how mucosal immune responses, infections and gut microbiome shape IgA nephropathy and future therapies","volume":"10","author":"He","year":"2020","journal-title":"Theranostics"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840160609","article-title":"Pulmonary hemorrhage and glomerulonephritis in primary biliary cirrhosis","volume":"16","author":"Bissuel","year":"1992","journal-title":"Hepatology"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfl638","article-title":"Primary biliary cirrhosis associated with minimal change disease","volume":"22","author":"Lai","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.54.3634","article-title":"Delayed development of primary biliary cirrhosis in a patient with acute glomerulonephritis: A possible pitfall of a self-limiting disease","volume":"54","author":"Miki","year":"2015","journal-title":"Intern Med"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000013172","article-title":"Primary biliary cirrhosis with refractory hypokalemia: A case report","volume":"97","author":"Dong","year":"2018","journal-title":"Med (Baltimore)"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfq232","article-title":"Tubulointerstitial nephritis and renal tubular acidosis of different types are rare but important complications of primary biliary cirrhosis","volume":"25","author":"Komatsuda","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfz059","article-title":"A patient with chronic kidney disease, primary biliary cirrhosis and metabolic acidosis","volume":"13","author":"Elitok","year":"2020","journal-title":"Clin Kidney J"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfl662","article-title":"Immunohistochemical comparison of a case of inherited distal renal tubular acidosis (with a unique AE1 mutation) with an acquired case secondary to autoimmune disease","volume":"22","author":"Walsh","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1997.140","article-title":"The kidney in mitochondrial cytopathies","volume":"51","author":"Niaudet","year":"1997","journal-title":"Kidney Int"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2005.05.021","article-title":"Tubulointerstitial nephritis and Fanconi syndrome in primary biliary cirrhosis","volume":"46","author":"Lino","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"B48","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s12882-015-0184-4","article-title":"A case of severe osteomalacia caused by tubulointerstitial nephritis with Fanconi syndrome in asymptomotic primary biliary cirrhosis","volume":"16","author":"Yamaguchi","year":"2015","journal-title":"BMC Nephrol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.5005\/jp-journals-10018-1145","article-title":"Autoimmune hepatitis with distal renal tubular acidosis and small bowel partial malrotation","volume":"5","author":"Kanaiyalal Modi","year":"2015","journal-title":"Euroasian J Hepatogastroenterol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.12659\/ajcr.933957","article-title":"Distal renal tubular acidosis associated with autoimmune diseases: Reports of 3 cases and review of mechanisms","volume":"23","author":"Silveira","year":"2022","journal-title":"Am J Case Rep"},{"key":"B51","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/s41581-023-00699-9","article-title":"The pathophysiology of distal renal tubular acidosis","volume":"19","author":"Wagner","year":"2023","journal-title":"Nat Rev Nephrol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1002\/ueg2.70011","article-title":"European consensus on malabsorption-UEG & SIGE, LGA, SPG, SRGH, CGS, ESPCG, EAGEN, ESPEN, and ESPGHAN: Part 2: Screening, special populations, nutritional goals, supportive care, primary care perspective","volume":"13","author":"Lenti","year":"2025","journal-title":"United Eur Gastroenterol J"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.1996.v23.pm0008550048","article-title":"Time course of histological progression in primary biliary cirrhosis","volume":"23","author":"Locke","year":"1996","journal-title":"Hepatology"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1053\/j.gastro.2014.08.029","article-title":"Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: an international follow-up study","volume":"147","author":"Lammers","year":"2014","journal-title":"Gastroenterology"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-050223-112947","article-title":"Update on hepatorenal syndrome: From pathophysiology to treatment","volume":"76","author":"Khemichian","year":"2025","journal-title":"Annu Rev Med"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.5114\/ceh.2021.111014","article-title":"Pentoxifylline mitigates cholestasis-related cholemic nephropathy","volume":"7","author":"Ommati","year":"2021","journal-title":"Clin Exp Hepatol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1159\/000489771","article-title":"Bile cast nephropathy: The unknown dangers of online shopping","volume":"8","author":"Fisler","year":"2018","journal-title":"Case Rep Nephrol Dial"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.nephro.2016.03.002","article-title":"Bile salt nephropathy\/cholemic nephrosis","volume":"12","author":"Leclerc","year":"2016","journal-title":"Nephrol Ther"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3390\/life11111200","article-title":"Cholemic nephropathy as cause of acute and chronic kidney disease. Update on an under-diagnosed disease","volume":"11","author":"Tinti","year":"2021","journal-title":"Life (Basel)"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1053\/j.akdh.2023.07.001","article-title":"Cholemic nephropathy: Role in acute kidney injury in cholestasis and cirrhosis","volume":"31","author":"Pinter","year":"2024","journal-title":"Adv Kidney Dis Health"},{"key":"B61","doi-asserted-by":"publisher","first-page":"102373","DOI":"10.1016\/j.xcrm.2025.102373","article-title":"Gut symbiont-derived ursodeoxycholic acid promotes fatty acid oxidation to protect against renal ischemia-reperfusion injury","volume":"6","author":"Xie","year":"2025","journal-title":"Cell Rep Med"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000002238","article-title":"Effectiveness of fenofibrate in treatment-naive patients with primary biliary cholangitis: A randomized clinical trial","volume":"118","author":"Liu","year":"2023","journal-title":"Am J Gastroenterol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1714519","article-title":"A placebo-controlled trial of bezafibrate in primary biliary cholangitis","volume":"378","author":"Corpechot","year":"2018","journal-title":"N Engl J Med"},{"key":"B64","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1056\/nejmoa2306185","article-title":"Efficacy and safety of elafibranor in primary biliary cholangitis","volume":"390","author":"Kowdley","year":"2024","journal-title":"N Engl J Med"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2312100","article-title":"A phase 3 trial of seladelpar in primary biliary cholangitis","volume":"390","author":"Hirschfield","year":"2024","journal-title":"N Engl J Med"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1845113\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T08:02:13Z","timestamp":1785398533000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1845113\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,30]]},"references-count":65,"alternative-id":["10.3389\/fimmu.2026.1845113"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1845113","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,30]]},"article-number":"1845113"}}